Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by GalaxyofLimeson Aug 24, 2019 10:06pm
135 Views
Post# 30063091

RE:RE:RE:RE:RE:RE:INSIDER SELLING!

RE:RE:RE:RE:RE:RE:INSIDER SELLING!Ledzep4u, Always nice to have decent dialogue on the bullboard. Weed has a huge problem with those options, at least for shareholders, and they are going to need to produce some spectacular sales to overcome the cheap options. The only way I see the share dramatically increasing in the short timeline is if Constellations further increases there position - maybe that is why Bruce has been so vocal about buying and holding a position, not saying he has insider knowledge, but he should know a bit more than us. Even when the sector starts to get some attention Canopy will not outperform just based upon the previous quarter.
ledzep4u wrote: This is something I've been posting for a while now. Bruce was giving away options like a drunken sailor and I disagreed with it because he was giving away the company at our expense as shareholders. 

He always justified it buy saying that everyone, from the janitor to senior manangement, deserved them becauase it made the employees take pride in their work because they owned a piece of the company. Meanwhile, the rest of us buy them on the open market at the full trading value at that moment. I find what Bruce did with awarding so many options, a disrespect to us retail investors and one of the reasons why it was time for Bruce to go.

If you look at the Q1 financials, Note 16, page 18 (link below) you will see there is still almost 31 millions in options left. There is still 6.2 million options left at $1.32 to $11.76/share as of June 30 and there was almost 3 million options exercised during Q1 by insiders. Sweet deal if you can get it, but not for us retail investors.

https://www.canopygrowth.com/wp-content/uploads/2019/08/Q1-FY2020-Financial-Statements-Final.pdf


Bullboard Posts